Meeting Emerging Stakeholder Needs With The Subcuject Wearable Bolus Injector

In this article, Tony Bedford, Director, Front-end Innovation, at Phillips-Medisize, looks at the emerging market for on-body injectors coupled with stakeholder needs and introduces the Subcuject wearable bolus injector, which is designed to accommodate these requirements.

September 2021 | ONdrugDELIVERY | Issue 124

Read the Article
Wearable Injectors_September 2021_ODD

View News, Blogs, and Other Resources

A Unique and Novel Technical Solution

Wearable Osmotic Bolus Injector

  • The simple osmotic drive provides a low-cost bolus injection technology, allowing wearable devices to be applied to a broader range of drugs
  • Meets growing demand for large-volume injectors to reduce injection frequency
  • Easy to use, the prefilled device supports in-home medication delivery, potentially moving more treatments out of hospital settings
A Unique and Novel Technical Solution
Read More

Wearable injectors are quickly becoming a meaningful alternative for patients in their home environments. See how Phillips-Medisize’s technology platforms not only help achieve efficacy, but also minimize incremental cost increases to pharmaceutical companies, healthcare payers, and patients.

Design for Manufacturing
Read Blog
Wearable Bolus Injector

This on-demand webinar highlights some of the challenges involved in developing a wearable bolus injector:

  • Learn about market trends for biologic and immuno-oncology drugs
  • Understand the stakeholder needs for wearable bolus injectors
  • Gain knowledge of the Phillips-Medisize and Subcuject wearable bolus injector
On-demand Webinar
Watch Now

This article is taken from ONdrugDELIVERY September 2021, pages 46-50.